DGAP-Ad hoc: Balda AG

DGAP-Adhoc: Balda AG: Management Board and Supervisory Board support the Offer of the Italian Stevanato Group in the amount of EUR 80 million regarding the purchase of the entire operating business - Extraordinary General Meeting probably at the end of January 2016

Balda AG / Key word(s): Disposal

15.12.2015 15:47

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Bad Oeynhausen, 15 December 2015 - As announced in an ad hoc announcement yesterday, Balda AG received a binding offer by the Italian Stevanato Group ("Stevanato") regarding the sale of its entire operating business at a purchase price of EUR 80 million on 14 December 2015.

The Annual General Meeting of Balda AG had already approved a binding offer by the Heitkamp & Thumann Group, Düsseldorf ("H&T"), concerning the sale of its entire operating business at a purchase price of EUR 74 million on 30 November / 1 December 2015. Balda AG so far has not accepted this offer.

The offer by Stevanato also comprises the sale of all operating units of the Balda Group, namely Balda Medical GmbH & Co. KG, Balda C. Brewer, Inc. and Balda Precision, Inc., both located in California, USA, as well as Balda Medical Systems SRL, Romania, and further assets. Moreover, Stevanato also offers to keep all employees of the operating units and take over staff of Balda AG. Contrary to H&T, Stevanato intends to also purchase the "Balda" brand and any associated (intangible) assets. The offer by Stevanato is also subject to prior approval by the General Meeting of Balda AG.

Meanwhile, the Management Board and the Supervisory Board have reviewed the offer by Stevanato in detail and, taking all facts into account, regard the offer by Stevanato preferable to the offer by H&T. In the next days, the Management Board will convene an extraordinary General Meeting which will presumably take place on 29 January 2016 in Hannover. At this extraordinary General Meeting, the offer by Stevanato will be submitted to the General Meeting for approval.

Contact / Contact Person: Michael Pfister Deekeling Arndt Advisors tel: +49 (0) 5734 922 2555 moble: +49 (0) 160 90560506 email: michael.pfister@deekeling-arndt.de

About Balda Balda (ISIN: DE0005215107) is a provider of high-end plastics solutions that rely on quality in sophisticated fields of application in the healthcare, lifestyle, automotive and consumer electronics industry. Balda operates in Europe and Northern America and has state of the art production sites at the Oeynhausen headquarters in Germany and in the US. The company's success with its about 800 staff worldwide is based on the use of modern, cost-efficient technologies and the close cooperation with our customers in a spirit of trust. www.balda-group.com

15.12.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de

--------------------------------------------------------------------------- Language: English Company: Balda AG Bergkirchener Str. 228 32549 Bad Oeynhausen Germany Phone: +49 (0) 57 34 / 9 22-0 Fax: +49 (0) 57 34 / 9 22-2604 E-mail: ir@balda-group.com Internet: www.balda-group.com ISIN: DE0005215107 WKN: 521510 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------